Ventilator Settings in Bronchopleural Fistula
In adult patients with bronchopleural fistula requiring mechanical ventilation, prioritize minimizing air leak by using low tidal volumes (4–6 ml/kg PBW), minimal PEEP (0–5 cmH₂O), reduced peak inspiratory pressures (<20 cmH₂O when possible), prolonged expiratory time, and lower respiratory rates (8–12 breaths/min), while accepting permissive hypercapnia (pH >7.20). 1
Core Ventilator Strategy: Minimize Transpulmonary Pressure Gradient
The fundamental principle is reducing the driving pressure across the fistula by decreasing the difference between airway pressure and pleural pressure. 1 Every ventilator adjustment should aim to reduce air leak through the BPF while maintaining acceptable gas exchange.
Tidal Volume Settings
- Set tidal volume at 4–6 ml/kg predicted body weight, which is lower than standard lung-protective ventilation. 1
- This represents the most critical intervention to reduce peak inspiratory pressure and minimize fistula flow. 1
- Accept that lower tidal volumes will result in hypercapnia; this is preferable to high airway pressures that perpetuate the fistula. 1
PEEP Management
- Use minimal or zero PEEP (0–5 cmH₂O), contrary to standard ARDS management. 2, 3, 1
- PEEP directly increases the transpulmonary pressure gradient and worsens air leak through the BPF. 1
- In one case report, reducing PEEP from 22 cmH₂O allowed successful management of a BPF with 75% tidal volume leak. 3
- This is the single most important deviation from standard lung-protective ventilation guidelines. 1
Peak Inspiratory Pressure
- Target peak inspiratory pressure <20 cmH₂O whenever possible, though this may require accepting significant hypercapnia. 1
- Higher peak pressures directly correlate with increased fistula flow and prevent fistula closure. 2, 1
- Monitor peak pressure continuously as the primary determinant of fistula leak volume. 1
Respiratory Rate and Timing
- Set respiratory rate at 8–12 breaths/min, lower than conventional settings. 1
- Use prolonged expiratory time with I:E ratio of 1:2 to 1:3 to allow complete exhalation and minimize auto-PEEP. 1
- Reducing respiratory rate decreases minute ventilation and cumulative air leak over time. 1
Permissive Hypercapnia
- Accept arterial pH >7.20 and PaCO₂ up to 80–90 mmHg rather than increasing minute ventilation. 4, 1
- Attempts to normalize blood gases by increasing tidal volume or respiratory rate will worsen the fistula and prevent healing. 1
- This strategy has been safely employed in multiple case reports of successful BPF management. 2, 3, 5
Chest Tube Management
- Maintain chest tube to water seal (no suction) or minimal suction (–10 to –20 cmH₂O) to minimize negative intrapleural pressure. 1
- High-level chest tube suction (e.g., –40 cmH₂O) increases the transpulmonary pressure gradient and perpetuates air leak. 1
- In refractory cases, consider adding positive pressure to the pleural space to reduce the expiratory transpulmonary pressure difference. 3
Advanced Ventilatory Modes for Refractory Cases
Independent Lung Ventilation
- Consider independent lung ventilation using a double-lumen endotracheal tube when conventional ventilation fails. 2, 6, 1
- Ventilate the affected lung with very low tidal volumes (200 ml) and higher rates, while ventilating the unaffected lung with standard settings. 2
- This allows targeted reduction of airway pressure to the fistula-containing lung while maintaining adequate ventilation of the healthy lung. 2, 6
High-Frequency Ventilation
- High-frequency jet ventilation (HFJV) or high-frequency oscillatory ventilation (HFOV) can dramatically reduce fistula leak when conventional ventilation fails. 6, 5
- HFJV uses very small tidal volumes (1–3 ml/kg) at high rates (100–150 breaths/min), minimizing peak pressures while maintaining gas exchange. 6
- In one case, HFOV reduced BPF leak from 530 ml/breath to 100 ml/breath over 28 days, allowing fistula healing. 5
- These modes should be reserved for high-output fistulas (>50% tidal volume leak) unresponsive to conventional low-pressure strategies. 6, 5, 1
Extracorporeal Membrane Oxygenation
- Consider veno-venous ECMO for refractory hypoxemia or hypercapnia when ventilator settings cannot be reduced further without life-threatening gas exchange failure. 1
- ECMO allows near-apneic ventilation (tidal volume 2–4 ml/kg, rate 4–6 breaths/min), minimizing fistula flow and promoting closure. 1
- This is appropriate only in centers with ECMO capability and when the patient is otherwise a surgical candidate for definitive repair. 1
Monitoring Parameters
- Measure fistula leak volume at each ventilator change by comparing delivered tidal volume to exhaled tidal volume. 1
- Continuously monitor peak inspiratory pressure, plateau pressure, and auto-PEEP as determinants of transpulmonary pressure. 1
- Obtain arterial blood gases 30–60 minutes after each ventilator adjustment to assess tolerance of permissive hypercapnia. 7
- Document chest tube output and air leak pattern (continuous vs. intermittent) to guide management. 1
Critical Pitfalls to Avoid
- Do not apply standard ARDS lung-protective ventilation with PEEP ≥5 cmH₂O; this will worsen the fistula despite being guideline-recommended for other conditions. 4, 7, 1
- Do not attempt to normalize arterial blood gases by increasing tidal volume or respiratory rate; this perpetuates the fistula and prevents healing. 1
- Do not use high-level chest tube suction (>–20 cmH₂O); this increases the transpulmonary pressure gradient and air leak. 1
- Do not delay consideration of advanced modes (independent lung ventilation, high-frequency ventilation, ECMO) in high-output fistulas; early intervention improves outcomes. 6, 5, 1
Definitive Management Considerations
- Bronchoscopic placement of endobronchial valves or occlusion devices should be considered for persistent fistulas not responding to ventilator management within 5–7 days. 1
- Surgical repair remains the definitive treatment but requires adequate pulmonary reserve and control of infection. 6, 1
- Ventilator management is a bridge to definitive therapy, not a standalone treatment. 1